North of the Border Overview of Biologics and Biosimilars in Canada


  • Overview of Canada’s Regulatory and Intellectual Property Regimes as they apply to Biologics and Biosimilars
  • The Regulatory Pathway for Marketing Approval, Data Protection, Patent Linkage and Litigation, and Current Biosimilar Approvals and Applications
  • A Comparison to the US and European Regimes: Differences and Similarities with Canada